Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Abstract HIV post- exposure prophylaxis (PEP) is a prevention tool for individuals with a recent potential exposure to HIV. Doravirine has been available since 2019 in combination with tenofovir disoproxil fumarate and lamivudine and has not been evaluated as a PEP. DOR/3TC/TDF is our department’s m...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Inès Devred, Kick Kayembe, Nadia Valin, Hayette Rougier, Bruce Wuembulua Shinga, Sidonie Lambert-Niclot, Thibault Chiarabini, Marie-Caroline Meyohas, Karine Lacombe
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2023-09-01
Serie:	BMC Infectious Diseases
Ämnen:	Post-exposure prophylaxis Doravirine HIV Adherence Completion rate
Länkar:	https://doi.org/10.1186/s12879-023-08544-x
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!